SoperSparks271

The researchers examined four drugs: Allegra, Arava, Amaryl and Zithromax. In the second half of 2005, each one of these drugs come to an end of patent protection. Their universal equivalents were obtained instead at an average factor of 87 percent within 1 month of the equivalents distribution at pharmacies.

The investigation was prepared by Medco Health Solutions Inc. Situated in Frankin Lakes, that is the greatest drug profit management company in U.S. The company bargains for low prices of prescription drug on behalf of its clients.

Based on the study, Zithromax, the hit of Pfizer Inc. with its annual sales of $1.85 million was quickly substituted at pharmacies by generic equivalent at a 90 % rate just after it lost its patent protection in November.

The analysis authors described the replacement of Zithromax, an for respiratory infections, as proof that more and more doctors propose common types of brand name drugs more quickly, even if it is about alleged acute care drugs, such as Zithromax.

The really good news is that these four common medicines are just the start. With a number of popular medications likely to go off patent next several years, substantial prescription drug costs savings should be seen by us - reported a senior vice president, Dr. Glen Stettin.

A spokeswoman at Medco, Ann Smith said that more than 70 manufacturer drugs, including 19 blockbusters, are losing their patent protection within the next five years - with total yearly sales of $45 billion.

If Medcos study reveals a development, in the coming years consumers, employers and insurance firms helps you to save huge amounts of dollars in prescription drug - Smith said.

The information met with enthusiastic response from consumer groups.

We hope the pattern continues. Its good for customers, revealed Bill Vaughan, senior policy analyst for an group, Consumer Union, based in Washington, D.C.

Vaughan mentioned that past doubts regarding the safety and performance of common drugs have apparently started to fade away as society has become more concerned about rapid increase of health-care costs.

The FDA approves these generic drugs since they have been established in the same way safe and effective as their brand name counterparts, however, you pay a fraction of the price, Vaughan reported. We think this really is very positive and can save customers literally billions of dollars next couple of years.

At once, large pharmaceutical companies have stated that their brand name drugs will not be taken by knockoffs as insurers and doctors realize that the brand name drugs promise better treatment and in consequence - cut costs.

Hank McKinnell, Pfizer Chairman used that argument all through last session with analysts in New York.

In the event that you dont such as the high cost of healthcare, try the high cost of nausea, McKinnell advised. go here